ATE221370T1 - Durchscheinende kollagenformulierungen - Google Patents

Durchscheinende kollagenformulierungen

Info

Publication number
ATE221370T1
ATE221370T1 AT96915471T AT96915471T ATE221370T1 AT E221370 T1 ATE221370 T1 AT E221370T1 AT 96915471 T AT96915471 T AT 96915471T AT 96915471 T AT96915471 T AT 96915471T AT E221370 T1 ATE221370 T1 AT E221370T1
Authority
AT
Austria
Prior art keywords
translucent
compositions
collagen formulations
cytotoxic drug
collagen
Prior art date
Application number
AT96915471T
Other languages
English (en)
Inventor
Richard E Jones
Mike T Li
Original Assignee
Matrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharma filed Critical Matrix Pharma
Application granted granted Critical
Publication of ATE221370T1 publication Critical patent/ATE221370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96915471T 1995-04-28 1996-04-26 Durchscheinende kollagenformulierungen ATE221370T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/431,084 US5750146A (en) 1995-04-28 1995-04-28 Translucent collagen formulations with a cytotoxic drug
PCT/US1996/006210 WO1996033696A1 (en) 1995-04-28 1996-04-26 Novel collagen formulations

Publications (1)

Publication Number Publication Date
ATE221370T1 true ATE221370T1 (de) 2002-08-15

Family

ID=23710385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915471T ATE221370T1 (de) 1995-04-28 1996-04-26 Durchscheinende kollagenformulierungen

Country Status (14)

Country Link
US (2) US5750146A (de)
EP (1) EP0825848B1 (de)
JP (1) JPH11504904A (de)
KR (1) KR100437507B1 (de)
CN (1) CN1183039A (de)
AT (1) ATE221370T1 (de)
AU (1) AU719675B2 (de)
CA (1) CA2218037A1 (de)
DE (1) DE69622706T2 (de)
DK (1) DK0825848T3 (de)
ES (1) ES2180776T3 (de)
NZ (1) NZ307791A (de)
PT (1) PT825848E (de)
WO (1) WO1996033696A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US6673370B2 (en) * 2001-05-15 2004-01-06 Biomedicines, Inc. Oxidized collagen formulations for use with non-compatible pharmaceutical agents
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
EP2365815B1 (de) * 2008-11-14 2019-09-18 Histogen, Inc. Extrazelluläre matrix-zusammensetzungen zur behandlung von krebs
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers
US9782457B2 (en) * 2011-10-07 2017-10-10 Tissue Repair Company Flowable formulations for tissue repair and regeneration
US9452240B2 (en) 2013-03-15 2016-09-27 Orthovita, Inc. Pepsinized collagen implants and biomedical uses thereof
EP3675912B1 (de) * 2017-10-12 2024-01-10 SolyPlus GmbH Verfahren zur herstellung von konzentrierten und homogen benetzten massiven polymeren und anwendungen davon

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33375A (en) * 1861-10-01 Improvement in pumps
US2589210A (en) * 1945-09-24 1952-03-18 Parke Davis & Co Therapeutic compositions
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US4863732A (en) * 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
ES2045404T3 (es) * 1988-02-11 1994-01-16 Matrix Pharma Composiciones para tratar tumores intracraneales.
US5480644A (en) * 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters

Also Published As

Publication number Publication date
US5980946A (en) 1999-11-09
ES2180776T3 (es) 2003-02-16
DK0825848T3 (da) 2002-11-11
AU5723796A (en) 1996-11-18
DE69622706D1 (de) 2002-09-05
JPH11504904A (ja) 1999-05-11
NZ307791A (en) 1999-04-29
AU719675B2 (en) 2000-05-18
EP0825848A4 (de) 1998-08-12
CN1183039A (zh) 1998-05-27
WO1996033696A1 (en) 1996-10-31
DE69622706T2 (de) 2003-03-13
KR100437507B1 (ko) 2004-08-16
EP0825848B1 (de) 2002-07-31
KR19990008143A (ko) 1999-01-25
CA2218037A1 (en) 1996-10-31
US5750146A (en) 1998-05-12
EP0825848A1 (de) 1998-03-04
PT825848E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
NO964976L (no) Kopolymer-1-forbedringer kopolymerpreparater
IT1276723B1 (it) Formulazioni di analoghi dell'insulina
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
EE9900413A (et) Medikamentide kontrollitud väljutamine silma eeskambrisse
SE8903042D0 (sv) Pharmaceutical compositions comprising cyklosporins
NO974498D0 (no) Monomere insulinanalogformuleringer
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
BR9908578A (pt) Composição cosmética
DK0825848T3 (da) Translucente collagenformuleringer
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
FI970934A0 (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
DE69108607D1 (de) Künstliche Zahnwurzel.
DE69608875D1 (de) Härtbare Siliconzusammensetzungen
DE69428456D1 (de) Silikon-modifizierte phospholipid-zusammensetzungen
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
NO942023L (no) Stabiliserte polymersammensetninger
NO980296D0 (no) Forbedrede terapeutiske midler
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos
RS49608B (sr) Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje
ATE187339T1 (de) Auf helicobacter pylori katalase basierende immunisierende zusammensetzung
DE68914047D1 (de) Polymer-Zusammensetzungen.
ATE120369T1 (de) Verwendung stabiler oxapenem-3-carbonsäuren zur herstellung beta-lactamase hemmender arzneimittel.
ITMI950507A0 (it) Composizioni polimeriche autoestinguenti
FR2710673B1 (fr) Composition d'enduit de parement.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee